Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningGranulocyte Colony-Stimulating FactorHematologic NeoplasmsLeukapheresisMelphalanGraft vs Host DiseaseAntigens, CD34Blood Component RemovalCombined Modality TherapyStem Cell TransplantationMyeloablative AgonistsCyclophosphamideHematopoietic Stem CellsMultiple MyelomaBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsBusulfanGraft SurvivalTreatment OutcomeLymphoma, Non-HodgkinStem CellsRemission InductionRecurrenceEtoposideThiotepaAntineoplastic Agents, AlkylatingCord Blood Stem Cell TransplantationTissue DonorsTransplantation ChimeraWhole-Body IrradiationHematopoiesisCarmustineDisease-Free SurvivalIfosfamideSalvage TherapyRetrospective StudiesHistocompatibilityHistocompatibility TestingCytophagocytosisVincristineSurvival RateHodgkin DiseaseCytarabineAmyloidosisSurvival AnalysisVidarabineTime FactorsNeoplasmsImmunosuppressive AgentsInfectionLeukemia, Myeloid, AcuteLeukemiaBlood Cell CountBlood CellsPlatelet CountRecombinant ProteinsDoxorubicinPOEMS SyndromeGraft vs Leukemia EffectTransplantation, IsogeneicUnrelated DonorsFollow-Up StudiesLymphoma, T-CellMyelodysplastic SyndromesLymphomaCarboplatinLiver TransplantationBone Marrow PurgingCytomegalovirus InfectionsPrednisoneHematologic DiseasesAnemia, AplasticAntineoplastic AgentsProspective StudiesHLA AntigensDexamethasoneLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFeasibility StudiesGraft vs Tumor EffectLymphocyte DepletionT-LymphocytesImmunophenotypingCyclosporineSiblingsFatal OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaBlood DonorsBone MarrowLeukocytes, MononuclearFlow CytometryImmunosuppressionTransplantation ImmunologyCell SeparationMesenchymal Stem Cell TransplantationBone Marrow Cells